Personalized chemo dosing aims to boost surgery success for stomach cancer
NCT ID NCT02366819
First seen May 05, 2026 · Last updated May 19, 2026 · Updated 4 times
Summary
This study tests whether adjusting chemotherapy doses based on a patient's genetics can improve outcomes for people with advanced stomach or esophageal cancer that has spread to nearby tissues or lymph nodes. About 36 participants will receive a chemotherapy regimen called mFOLFIRINOX before and after surgery. The main goal is to see if this approach helps surgeons completely remove the tumor (called R0 resection).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kellogg Cancer Center - Evanston Hospital
Evanston, Illinois, 60201, United States
-
NorthShore University HealthSystem
Evanston, Illinois, 60201, United States
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.